АЛГОРИТМЫ НАЗНАЧЕНИЯ ХОЛЕКАЛЬЦИФЕРОЛА ДЛЯ ТЕРАПИИ И ПРОФИЛАКТИКИ D-ГИПОВИТАМИНОЗА ПРИ АРТЕРИАЛЬНОЙ ГИПЕРТЕНЗИИ
Аннотация
Цель работы – проанализировать литературные и собственные данные по назначению холекальциферола для терапии и профилактики D-гиповитаминоза при артериальной гипертензии (АГ) с учетом факторов риска и комбинированной антигипертензивной терапии. Результаты анализа литературных данных и выполненного нами проспективного, контролируемого, рандомизированного, сравнительного, одноцентрового клинического исследования 173 пациентов с АГ II степени с приемом холекальциферола в дозе 2000 МЕ/сутки на протяжении 3, 6 и более месяцев позволили предложить алгоритмы назначения холекальциферола для терапии и профилактики D-гиповитаминоза при АГ.
Литература
Burgaz A, Orsini N, Larsson SC, Wolk A. Blood 25-hydroxyvitamin D concentration and hypertension: a meta-analysis. Journal of Hypertension. 2011;29(4):636-645. https://doi.org/10.1097/HJH.0b013e32834320f9
Forman JP, Scott JB, Ng K, Drake BF, Suarez EG, Hayden DL, Bennett GG, Chandler PD, Hollis BW, Emmons KM, Giovannucci EL, Fuchs CS, Chan AT. Effect of vitamin D supplementation on blood pressure in blacks. Hypertension. 2013;61(4):779-785. https://doi.org/10.1097/HJH.0b013e32832f075b
Witham MD, Nadir MA, Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. Journal of Hypertension. 2009;27(10):1948-1954. https://doi.org/10.1097/HJH.0b013e32832f075b
Kunutsor SK, Burgess S, Munroe PB, Khan H. Vitamin D and high blood pressure: causal association or epiphenomenon. European Journal of Epidemiology. 2014;29(1):1-14. https://doi.org/10.1007/s10654-013-9874-z
Sugden JA, Davies JI, Witham MD, Morris AD, Struthers AD. Vitamin D improves endothelial function in patients with Type 2 diabetes mellitus and low vitamin D levels. Diabetic Medicine. 2008;25(3):320-325. https://doi.org/10.1111/j.1464-5491.2007.02360.x
Witham MD, Dove FJ, Dryburgh M, Sugden JA, Morris AD, Struthers AD. The effect of different doses of vitamin D(3) on markers of vascular health in patients with type 2 diabetes: a randomised controlled trial. Diabetologia. 2010;53(10):2112-2119. https://doi.org/10.1007/s00125-010-1838-1
Larsen T, Mose FH, Bech JN, Hansen AB, Pedersen EB. Effect of cholecalciferol supplementation during winter months in patients with hypertension: A randomized, placebo-controlled trial. American Journal of Hypertension. 2012;25(11):1215-1222. https://doi.org/10.1038/ajh.2012.111
Pilz S, Gaksch M, Kienreich K, Grübler M, Verheyen N, Fahrleitner-Pammer A, Treiber G, Drechsler C, Ó Hartaigh B, Obermayer-Pietsch B, Schwetz V, Aberer F, Mader J, Scharnagl H, Meinitzer A, Lerchbaum E, Dekker JM, Zittermann A, März W, Tomaschitz A. Effects of vitamin D on blood pressure and cardiovascular risk factors: A randomized controlled trial. Hypertension. 2015;65(6):1195-1201. https://doi.org/10.1161/HYPERTENSIONAHA.115.05319
Banerjee D, Goldsmith D. Effect of Vitamin D on Endothelial Function and Blood Pressure. In: Goldsmith DJA, Covic A, Spaak J, eds. Cardio-Renal Clinical Challenges. London; 2015. Ch. 10; p. 99-105. https://doi.org/10.1007/978-3-319-09162-4_10
Tarcin O, Yavuz DG, Ozben B, Telli A, Ogunc AV, Yuksel M, Toprak A, Yazici D, Sancak S, Deyneli O, Akalin S. Effect of vitamin D deficiency and replacement on endothelial function in asymptomatic subjects. Journal of Clinical Endocrinology and Metabolism. 2009;94(10):4023-4030. https://doi.org/10.1210/jc.2008-1212
Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, Shah Y, Zhu H, Dong Y. Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. American Journal of Hypertension. 2011;24(5):557-562. https://doi.org/10.1038/ajh.2011.12
Gepner AD, Ramamurthy R, Krueger DC, Korcarz CE, Binkley N, Stein JH. A prospective randomized controlled trial of the effects of vitamin D supplementation on cardiovascular disease risk. PLoS One. 2012;7(5):e36617. https://doi.org/10.1371/journal.pone.0036617
Longenecker CT, Hileman CO, Carman TL, Ross AC, Seydafkan S, Brown TT, Labbato DE, Storer N, Tangpricha V, McComsey GA. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo- controlled trial. Antiviral Therapy. 2012;17(4):613-621. https://doi.org/10.3851/IMP1983
Sowers MR, Wallace RB, Hollis BW. The relationship of 1,25-dihydroxyvitamin D and radial bone mass. Journal of Bone and Mineral. 1990;10(2):139-148. https://doi.org/10.1016/0169-6009(90)90089-X
Yankouskaya L, Snezhitskiy V, Povoroznyuk V, Lyalikov S. Vlijanie na uroven 25-gidroksivitamina D i arterialnoe davlenie dopolnitelnogo priema holekalciferola pri antigipertenzivnoj terapii [Effect of supplemental intake of cholecalciferol on the level of 25-hydroxyvitamin D and blood pressure in antihypertensive therapy]. Kardiologija v Belarusi [Cardiology in Belarus]. 2015;5(42):140-150. (Russian).
Yankouskaya LV, Snezhitskiy VA, Lyalikov SA, Pludowski P, Semyachkina-Glushkovskaya OV. Pozitivnye jeffekty priema holekalciferola na uroven lipidov plazmy krovi u lic s arterialnoj gipertenziej [Positive effects of cholecalciferol supplementation on plasma lipid levels in patients with arterial hypertension]. Zhurnal Grodnenskogo gosudarstvennogo medicinskogo universiteta [Journal of the Grodno State Medical University]. 2015;3(51):78-84. (Russian).
Yankouskaya L, Kezhun L, Slobodskaya N. Vlijanie priema holekalciferola na aktivnost renina plazmy i funkciju jendotelija u lic s arterialnoj gipertenziej [Effect of supplemental intake of cholecalciferol on the plasma renin activity and endothelial function in patients with arterial hypertension]. Recept [Recipe]. 2016;19(5):542-553. (Russian).
Yakubova L, Kezhun L, Semyachkina-Glushkovskaya O. Izmenenie aktivnosti renina plazmy i funkcii jendotelija u lic s arterialnoj gipertenziej pri terapii s vkljucheniem ingibitora angiotenzinprevrashhajushhego fermenta i holekalciferola [Changes in plasma renin activity and endothelial function in patients with arterial hypertensionwith inclusion in therapy inhibitor of angiotensin-converting enzyme and cholecalciferol]. Recept [Recipe]. 2017;20(6):568-577. (Russian).
Yankovskaya LV, Snezhitskiy VA, Novogran V. Vzaimosvjaz urovnja vitamina D s aktivnostju renina plazmy u pacientov s arterialnoj gipertenziej [The relationship between vitamin D levels and plasma renin activity in patients with arterial hypertension]. Klinicheskaja medicina [Clinical medicine]. 2017;95(9):803-809. https://doi.org/10.18821/0023-2149-2017-95-9-803-809 (Russian).
Yankouvskaya LV, Snezhitskiy VA, Mamedov MN. Vlijanie priema holekalciferola i diuretikov v sostave kombinirovannoj antigipertenzivnoj terapii na aktivnost renina plazmy i funkciju jendotelija u lic s arterialnoj gipertenziej [Effect of cholecalciferol and diuretics as components of combination antihypertensive therapy on plasma renin activity and endothelial function in patients with arterial hypertension]. Kardiologija [Cardiology]. 2017;57(8):34-39. https://doi.org/10.18087/cardio.2017.8.10015 (Russian).
Yankouskaya LV, Snezhitskiy VA, Lyalikov SA, Slobodskaya NS, Kezhun LV. Vlijanie priema profilakticheskih doz holekalciferola u lic s arterialnoj gipertenziej na pokazateli kalcij-fosfornogo obmena i vospolnenie urovnja vitamina D [Effect of prophylactic doses of cholecalciferol in subjects with arterial hypertension on the indices of calcium-phosphorus exchange and vitamin D level improvement]. Medicinskie novosti [Medical news]. 2015;12:33-36. (Russian).
Shanahan CM, Crouthamel MH, Kapustin A, Giachelli CM. Arterial calcification in chronic kidney disease: key roles for calcium and phosphate. Circulation Research. 2011;109(6):697-711. https://doi.org/10.1161/CIRCRESAHA.110.234914
Fitzpatrick LA, Bilezikian JP, Silverberg SJ. Parathyroid hormone and the cardiovascular system. Current Osteoporosis Reports. 2008;6(2):77-83. https://doi.org/10.1007/s11914-008-0014-8
Dhingra R, Sullivan LM, Fox CS, Wang TJ, D'Agostino RB Sr, Gaziano JM, Vasan RS. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Archives of Internal Medicine. 2007;167(9):879-885. https://doi.org/10.1001/archinte.167.9.879
Spiegel DM, Brady K. Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets. Kidney International. 2012;81(11):1116-1122. https://doi.org/10.1038/ki.2011.490
Yankouskaya LV, Snezhitskiy VA, Lyalikov SA. Kalcijfosfornyj obmen u zhenshhin s arterialnoj gipertenziej [Relationship between calcium-phosphorus metabolism, vitamin D level and blood pressure in women with arterial hypertension]. Kardiologija v Belarusi [Cardiology in Belarus]. 2013;5(30):74-85. (Russian).
Wang H, Xia N, Yang Y, Peng DQ. Influence of vitamin D supplementation on plasma lipid profiles: a meta-analysis of randomized controlled trials. Lipids in Health Disease. 2012;11:42. https://doi.org/10.1186/1476-511X-11-42
Schwetz V, Scharnagl H, Trummer C, Stojakovic T, Pandis M, Grübler MR, Verheyen N, Gaksch M, Zittermann A, Aberer F, Lerchbaum E, Obermayer-Pietsch B, Pieber TR, März W, Tomaschitz A, Pilz S. Vitamin D supplementation and lipoprotein metabolism: a randomized controlled trial. Journal of Clinical Lipidology. 2018;12(3):588-596. https://doi.org/10.1016/j.jacl.2018.03.079
Qin XF, Zhao LS, Chen WR, Yin DW, Wang H. Effects of vitamin D on plasma lipid profiles in statin-treated patients with hypercholesterolemia: A randomized placebo-controlled. Clinical Nutrition. 2014;34(2):201-206. https://doi.org/10.1016/j.clnu.2014.04.017
Tavakoli F, Namakin K, Zardast M. Vitamin D supplementation and high-density lipoprotein cholesterol: a study in healthy school children. Iranian Journal of Pediatrics. 2016;26(4):e3311. https://doi.org/10.5812/ijp.3311
